News

Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology

Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.

COVID-19 medical imaging examples of various clinical presentations. SARS-CoV-2 clinical imaging presentations.

PHOTO GALLERY: What does acute COVID-19 and long COVID look like on medical imaging?

This image gallery shows what the various clinical presentations associated with the COVID-19 and long COVID that have been documented during and after coronavirus pandemic.

Illustration showing how procizumab captures circulating dipeptidyl peptidase 3 (cDPP3) to block this key molecular driver of shock. Illustrations courtesy of 4TEEN4

$64M raised for new cardiogenic shock drug—research already underway

Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.

Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services.

Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

Machine learning model predicts which radiotherapy patients are most vulnerable to adverse side effects

The model integrates structured EHR data spanning patient characteristics, cancer treatment, vitals, lab results, medications and prior acute care utilization to determine an individual’s risk of requiring urgent care throughout the course of their treatment.

AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.

Researchers' testing of industrial dyes could lead to the development of dementia-specific imaging agents

There are dozens of different subtypes of dementia, and it can be a challenge to determine the exact type affecting a patient.

AI for opportunistic osteoporosis screening inks FDA clearance

The tool analyzes routine hip and pelvis X-rays for signs of low bone mineral density.

Dana Smetherman, MD, MPH, MBA, FACR, chief executive officer of the American College of Radiology (ACR), explains ACR efforts to help members understand and enable easier integration of artificial intelligence (AI) into practice while also ensuring it can be trusted.

ACR expands programs to help radiology practices integrate and trust AI

CEO Dana Smetherman, MD, MPH, MBA, explains American College of Radiology efforts to help members understand and enable easier integration of artificial intelligence.

Breast cancer AI ribbon pink artificial intelligence

Short-term breast cancer risk prediction improves when AI combines imaging with personal info

Understanding which women have the greatest short-term risk could enable providers to implement targeted screening strategies to ensure malignancies are caught at the earliest possible stage.

Around the web

Radiology Business